Tumor microenvironment models: ex vivo, in vitro and in silico approaches to address targeted therapies
Year: 2020
Type: dissertation
Abstract: "Cancer is the second leading cause of mortality worldwide, despite the extraordinary advances in the last two decades due to the development of targeted therapies. These target particular molecules required for cell growth and tumorigenesis; nonetheless, de novo or acquired resistance to therapy often lead to patient relapse and disease progression. There is cumulating evidence supporting the importance of tumor microenvironment (TME)-driven mechanisms in cancer progression and drug resistance. Therefore, there is a need for cancer models in which critical components of the TME, such as the non-malignant cell types and the extracellular matrix (ECM), are represented and tissue architecture is maintained. (...)"
Author: Ana Luísa Cartaxo
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G21277220, Implementation of The Discoveries Centre for Regenerative and Precision Medicine, a new Centre of Excellence in Portugal, Doctoral Program MIT Portugal Bio-Engineering Systems "Unravelling the tumor microenvironment: study of the immune infiltrate influence on antibody therapy response using patient-derived breast cancer cell models", G2673245850, G738544523, G745058283, G7688748341, G7858748947, The Integrated Initiative of European Laser Research Infrastructures, G8839327758, iNOVA4Health - Programa de Medicina Translacional (iBET, CEDOC/FCM, IPOLFG e ITQB)
OpenAlex ID: W3102229277
